Test Results Demonstrate Excellent Sensitivity and Specificity and 92% Correlation with Final Histopathology BOSTON, Feb. 14, 2013 -- (Healthcare Sales & Marketing Network) -- Dune Medical Devices, Inc., announced today that its breakthrough tissue ass...
Devices, Diagnostics, Oncology
Dune Medical Devices, MarginProbe, vacuum assisted breast biopsy, breast biopsy

SAN DIEGO, Feb. 14, 2013 -- (Healthcare Sales & Marketing Network) -- Elcelyx Therapeutics announced today the closing of a $20 million Series C financing to fund development of product candidates NewMet™ for Type 2 diabetes and Lovidia™, an over-the-coun...
Biopharmaceuticals, Venture Capital, Personnel
Elcelyx Therapeutics, NewMet, Lovidia, obesity

Enables Cardinal Health to serve the growing population of aging and chronically ill as care moves increasingly to the home Expands Cardinal Health's ability to deliver cost-effective solutions across the continuum of care, broadening product portfolio ...
Devices, Distribution, Mergers & Acquisitions
Cardinal Health, AssuraMed

New treatment for the induction of remission of active, mild to moderate ulcerative colitis SAN DIEGO--(Healthcare Sales & Marketing Network)--Santarus, Inc. (SNTS) announced today the U.S. commercial launch of UCERIS™ (budesonide) extended release tabl...
Biopharmaceuticals, Gastroenterology
Santarus, UCERIS , budesonide, ulcerative colitis

CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Verastem, Inc., (VSTM), a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the filing of o...
Biopharmaceuticals, Oncology, Regulatory, FDA
Verastem, VS-6063, mesothelioma, orphan drug designation

IP protection includes PICSO® method and algorithms that ensure stable and repeatable PICSO® treatment designed to enhance myocardial perfusion following primary PCI in STEMI patients VIENNA--(Healthcare Sales & Marketing Network)--Miracor Medic...
Devices, Interventional Cardiology
Miracor Medical Systems, PICSO System, STEMI patients, angioplasty

New Breakthrough Report Reaffirms Proton Therapy Efficacy; Post-Treatment Quality of Life on Par with Men Never Afflicted by Cancer LOMA LINDA, Calif.--(Healthcare Sales & Marketing Network)--A staggering 99 percent of prostate cancer patients treated w...
Devices, Oncology
Loma Linda University Medical Center, proton therapy, radiotherapy, proton beam

Loma Vista Medical has established a direct sales force within the United States and a network of seven European distributors working to commercialize the world’s first ultra-precise balloon catheter specifically designed to meet the demands of transcathet...
Devices, Interventional Cardiology, Distribution
Loma Vista Medical, TRUE Dilatation Balloon, Valvuloplasty

LUND, Sweden, Feb. 13, 2013 -- (Healthcare Sales & Marketing Network) -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today that ...
Devices, Orthopaedic, Regulatory, Product Launch
BONESUPPORT, CERAMENT, bone graft substitute

LOS ANGELES, CA--(Healthcare Sales & Marketing Network) - Ritter Pharmaceuticals, Inc. today announced the appointment of Larry I. Good, M.D., F.A.C.G. to the position of Chief Medical Officer. Dr. Good's extensive experience as a practicing gastroenterolo...
Biopharmaceuticals, Gastroenterology, Personnel
Ritter Pharmaceuticals, lactose intolerance

SAN CARLOS, Calif.--(Healthcare Sales & Marketing Network)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today the appointment ...
Biopharmaceuticals, Oncology, Personnel
Cellerant Therapeutics, hematopoietic stem cell, stem cell

New System Completes Portfolio of Cooled Radiofrequency Treatment for the Spine ROSWELL, Ga., Feb. 13, 2013 -- (Healthcare Sales & Marketing Network) -- Kimberly-Clark today announced the launch of CERVICOOL Cooled Radiofrequency (RF) System, an innova...
Devices, Orthopaedic, Product Launch
Kimberly-Clark, CERVICOOL, Cooled RF System, facet joint

SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Lpath, Inc. ( NASDAQ : LPTN ), the industry leader in bioactive lipid-targeted therapeutics, has promoted Leigh Hsu, Ph.D., to the new position of vice president of corporate development. Dr. Hsu h...
Biopharmaceuticals, Personnel
Lpath, ImmuneY2, iSONEP , ASONEP , Lpathomab, lipid-targeted therapeutics

NEW HAVEN, Conn.--(Healthcare Sales & Marketing Network)--Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the appointment of Jane Henderson as Senior Vice President and Chief Business Officer, effective immediately. Ms....
Biopharmaceuticals, Personnel
Kolltan Pharmaceuticals, receptor tyrosine kinase

STOCKHOLM, SWEDEN--(Healthcare Sales & Marketing Network) - Sobi (STO:SOBI.ST) announced that it has entered into a distribution agreement with PharmaSwiss to market the products Megace®, Monopril®, Cefzil® and Duricef® approved for the tre...
Biopharmaceuticals, Distribution
Swedish Orphan Biovitrum, PharmaSwiss, Megace, Monopri, Cefzil, Duricef

Revenue Milestone Reached Ahead of Schedule; Financing Round to Fund US Launch and International Distribution Plans for Cardiac Risk Test IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Aviir Inc., a biotechnology company dedicated to the preven...
Diagnostics, Cardiology, Venture Capital
Aviir, Aviir Diagnostic Laboratories, MIRISK VP, cardiac risk assessment

FORT LAUDERDALE, Fla., Feb. 12, 2013 -- (Healthcare Sales & Marketing Network) -- OrbusNeich Medical, Inc. ("OrbusNeich") announced that it received a favorable ruling from the European Patent Office ("EPO") yesterday in connection wit...
Devices, Interventional Cardiology
OrbusNeich Medical, Boston Scientific, Terumo, 482 patent, stents, helical stent

The Sherpa Pak™ Cardiac Transport System is intended to be used for the static hypothermic preservation of hearts, up to 4 hours, during transportation and eventual transplantation into a recipient, using cold storage solutions indicated for use with the h...
Devices, Cardiology, FDA
Paragonix Technologies, Sherpa Pak, Cardiac Transport System

IMMUNE TO PROVIDE EPICEPT WITH UP TO $0.5 MILLION IN WORKING CAPITAL HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(Healthcare Sales & Marketing Network)--Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (N...
Biopharmaceuticals, Mergers & Acquisitions
EpiCept, Immune Pharmaceuticals

CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Ironwood Pharmaceuticals, Inc. (IRWD) today announced the promotion of Mark Currie, Ph.D. to senior vice president, chief scientific officer (CSO), and president of research and development (R&D). ...
Biopharmaceuticals, Personnel
Ironwood Pharmaceuticals